Lead Product(s): Chinese Hamster Ovary K1 cell
Therapeutic Area: Oncology Product Name: Chosource
Highest Development Status: Discovery Platform Product Type: Cell and Gene therapy
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement July 29, 2020
TrueBinding will use Horizon’s cGMP-compliant CHOSOURCE™ platform for the development and commercialization of multiple biotherapeutic products for applications in immuno-oncology and other disease areas with great unmet medical need.